Related Experiment Video
Updated: Aug 13, 2025

07:54
Capillary Electrophoresis Mass Spectrometry Approaches for Characterization of the Protein and Metabolite Corona Acquired by Nanomaterials
Published on: October 27, 2020
4.5K
Nanoparticle protein corona: from structure and function to therapeutic targeting
Ghazal Bashiri1, Marshall S Padilla2, Kelsey L Swingle2
1Department of Bioengineering, Temple University, Philadelphia, PA 19122, USA. karin.wang@temple.edu.
Lab on a Chip
|January 19, 2023
Summary
Nanoparticle (NP) protein corona (PC) formation alters NP identity and function. Understanding protein conformation changes in the PC is key for optimizing NP therapeutics and modulating immune responses.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Nanoparticle (NP)-based therapeutics are advancing translational medicine.
- The formation of a protein corona (PC) on NPs in biological environments is not fully understood.
- The PC can significantly alter NP identity, bioactivity, stability, and biodistribution.
Purpose of the Study:
- To review biological factors influencing protein conformation within the PC.
- To examine protein conformation and orientation on four common NP types.
- To explore therapeutic applications leveraging protein conformation in the PC.
Main Methods:
- Literature review of biological factors affecting protein conformation.
- Detailed analysis of protein adsorption on selected NP types.
- Discussion of therapeutic strategies involving PC conformation control.
Main Results:
- Protein conformation and orientation in the PC are sensitive to biological factors and NP surface properties.
- Altered protein conformation can lead to changes in NP functionality.
- Specific NP types exhibit distinct protein adsorption patterns.
Conclusions:
- Understanding protein conformation in the PC is crucial for NP therapeutic development.
- Leveraging PC conformation offers potential for controlling NP behavior and immune responses.
- Further research is needed to fully explore the PC-NP interface for therapeutic innovation.

